A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• Glomus tumors are rare mesenchymal neoplasms originating from glomus cells.
• Malignant glomus tumors (glomangiosarcomas) of cutaneous origin are exceptionally rare, with fewer than 50 cases reported.
• The genetic underpinnings of cutaneous malignant glomus tumors remain largely uncharacterized.

Observation:

• This report details a rare case of a cutaneous malignant glomus tumor.
• Next-generation sequencing identified a unique CCND3 point mutation in the tumor.
• The identified mutation was not among previously documented genetic alterations in glomus tumors.

Findings:

• The identified CCND3 mutation may lead to cyclin D3 amplification.
• This finding expands the known genetic landscape of malignant glomus tumors.
• The study highlights the potential for novel genetic drivers in rare cancers.

Implications:

• CCND3 mutations could represent a therapeutic target in cutaneous malignant glomus tumors.
• CDK4/6 inhibitors may offer a new treatment strategy for patients with these tumors.
• Further research into CCND3 alterations is warranted for understanding and treating glomangiosarcomas.